Horror's Billion-Dollar Moment: Inside NPR's 'Fear' Series Finale
NPR's 'Fear' finale: a $1 million horror film grossed $400 million, fear researchers call scares a 'vaccine,' and Scott Simon isn't convinced.

Programme
- "Backrooms," made on a $1 million budget, grossed more than $400 million globally.
- Mathias Clasen of Aarhus University's Recreational Fear Lab calls recreational fear a "fear vaccine."
- Michael Clear of Blumhouse Atomic Monster says most ticket sales come from large groups buying together.
- Horror-only bookstores are opening across the United States.
- Author Stephen Graham Jones says horror monsters are built from personal fears — coaches, parents, bullies.
One horror film with a $1 million budget — "Backrooms" — earned back more than $400 million globally. That figure anchors the Halloween finale of NPR's "Fear" series, in which Weekend Edition Sunday host Ayesha Rascoe joined Scott Simon to ask what horror's commercial boom actually tells us about its audience.
The conversation was taped on Halloween, which Rascoe called "a high holiday for me." The series began with her own affection for the genre and a trip to Dickerson, Maryland, where she and producer Ryan Benk survived Markoff's Haunted Forest — a commercial haunt of the kind that, as Rascoe noted, draws millions of people spending "billions — and that's billions with a B" on attractions, screenings, costumes and candy.
What does all that spending buy?
Rascoe put the question to researchers. Mathias Clasen, codirector of the Recreational Fear Lab at Aarhus University in Denmark, framed managed fright as training.
"When you engage in recreational fear activities, you're essentially administering a fear vaccine," Clasen said.
Clasen's argument has two parts: being scared in controlled settings can prepare people for real-world horrors, and the experience is highly social. People report feeling closer to one another after what he called "a mini managed trauma together."
Simon was blunt: "Well, I'm not convinced." He also needled the institution itself — "recreational fear lab, that's... that's what happens these days?" Rascoe confirmed it exists.
Does a shared scare really bond people?
Rascoe ran a live experiment. She screened the opening scene of "Bring Her Back," which left Simon reacting to what he called "a grisly clown," and then the ending of "Nightmare on Elm Street," the 1984 Wes Craven film with Heather Langenkamp, Johnny Depp, Ronee Blakley and Amanda Wyss.
"So now, Scott, do you feel bonded?" Rascoe asked. "We've bonded, man."
Simon's answer: "I worship you, Ayesha, but I can't say I feel any closer." One data point; one failed replication.
Who is buying the tickets?
The industry side of the story tracks with the lab's claims. Horror bookstores devoted solely to the genre are opening across the country, and studios are chasing the returns. Rascoe spoke with leaders of Blumhouse Atomic Monster, the studio behind "Backrooms" and arguably the most successful horror operation working today.
"I think that one of the recent kind of developments is people are craving collective experiences," said Michael Clear, who heads the studio's emerging directors program. Most of the studio's ticket sales, he told NPR, come from large groups buying together, watching together and screaming together.
Is there a formula?
Simon pressed whether any scary story will do. Rascoe's answer: it has to be good, and good horror has craft. Author Stephen Graham Jones described his method to NPR — endings matter, and so do relatable characters.
"You build the monster from a bad coach you had, from a, you know, a parent you're having difficulties with, from a bully at school," Jones said. "You build them from who you're afraid of yourself."
Even villains, ghosts and slashers must let readers recognize what they fear, Jones argued, because fear is universal.
The economics suggest the appetite is not a fad: a million-dollar budget converting into $400 million signals an audience that keeps returning. Whether the "fear vaccine" thesis survives scrutiny, as Simon's skepticism hints, is a question the lab's own research — not the box office — will have to answer.
Source: NPR Arts
More from Tom Whitfield
Show full bio
Market editor covering people, launches and day-to-day practice in arts in the broadest sense at Arts & Voices.
974 articles



